市场调查报告书
商品编码
1402410
肠外营养市场-按成分(胺基酸、脂肪、碳水化合物、微量元素、维生素、矿物质)、类型(RTU、复合)、消费者(儿童和新生儿、成人)、最终用户(医院、诊所、家庭护理)与全球2023-2032 年预测Parenteral Nutrition Market-By Composition (Amino Acids, Fats, Carbohydrates, Trace Elements, Vitamins, Minerals), Type (RTU, Compounded), Consumer (Children and Newborns, Adults), End-user (Hospitals, Clinics, Homecare) & Global Forecast 2023-2032 |
在产业领导者产品推出激增的推动下,2023 年至 2032 年间,全球肠外营养市场CAGR将达到 7.1%。大公司引进先进的配方和输送系统来满足不同患者的需求。这些创新着重于改善营养成分、增强相容性和降低风险,从而推动市场扩张。
例如,2023 年 10 月,百特韩国推出了 Olimel N12E,这是一种富含蛋白质的全肠外营养 (TPN) 解决方案,专为重症患者量身定制,并由健康保险承保。每 1,000 毫升,Olimel N12E 含有 76 克氨基酸和 950 卡路里,与 Baxter 之前的复合维生素液 Olimel N9E 相比,氨基酸含量显着增加了 33%。这种增强作用在维持剂量的同时提高了胺基酸含量。有 1,000 mL、1,500 mL、2,000 mL 和更小的 650 mL 规格可供选择,患者可以灵活地选择液体容量以满足其营养需求。
由于这些尖端产品的出现,市场重点关註解决重症监护、肿瘤学和早产儿护理中的营养缺乏问题,从而标誌着满足全球特殊营养需求的关键时代。
肠外营养市场的总体份额根据成分、最终用户和地区进行分类。
从 2023 年到 2032 年,脂肪细分市场将经历重大发展。脂肪在为无法口服食物的患者提供必需营养素和热量方面发挥关键作用。这些脂质组成提供集中的能量来源,有助于维持健康的身体功能。随着医疗保健提供者优先考虑客製化营养,肠外营养解决方案中的脂肪对于解决营养不良、支持康復和满足不同医疗状况患者的特定饮食需求变得不可或缺。
2023 年至 2032 年,家庭护理机构的肠外营养市场规模将实现显着的CAGR。无法口服食物的家庭患者可以从客製化的肠外营养解决方案中受益。这些方便的疗法可确保患者透过静脉注射获得重要的营养物质,从而促进康復并维持健康。随着医疗保健转向以患者为中心的家庭护理,对肠外营养的需求不断增加,使具有复杂医疗需求的个人能够在舒适的家中获得必需的营养,提高他们的生活品质并帮助他们康復。
2023年至2032年,欧洲肠外营养产业将呈现出值得称讚的CAGR。随着人口老化和慢性病的盛行率上升,对专业营养支持的需求不断增加。肠外营养对于解决重症监护、营养不良和消化系统疾病变得至关重要。此外,配方和输注技术的进步也改善了患者的治疗效果。随着欧洲医疗保健系统优先考虑以患者为中心的护理,对客製化肠外营养解决方案的需求不断增加,反映出满足整个非洲大陆多样化营养需求的关键时代。
Global Parenteral Nutrition Market will witness 7.1% CAGR between 2023 and 2032, propelled by a surge in product launches by industry leaders. Major companies introducing advanced formulations and delivery systems cater to diverse patient needs. These innovations focus on improved nutrient profiles, enhanced compatibility, and reduced risks, driving market expansion.
For instance, in October 2023, Baxter Korea unveiled Olimel N12E, a protein-rich Total Parenteral Nutrition (TPN) solution tailored for critically ill patients and covered by health insurance. With each 1,000 mL, Olimel N12E packs 76 grams of amino acids and 950 calories, presenting a significant 33 percent boost in amino acids compared to Baxter's prior multivitamin fluid, Olimel N9E. This enhancement maintains dosage while elevating the amino acid content. Available in 1,000 mL, 1,500 mL, 2,000 mL, and a smaller 650 mL size, patients gain flexibility in selecting fluid volumes to match their nutritional needs.
With an emphasis on addressing nutritional deficiencies in critical care, oncology, and premature infant care, the market experiences an upswing due to these cutting-edge offerings, marking a pivotal era in meeting specialized nutritional requirements globally.
The overall Parenteral Nutrition Market share is classified based on the composition, end-user, and region.
Fats segment will undergo significant development from 2023 to 2032. Fats play a pivotal role in providing essential nutrients and calories crucial for patients unable to consume food orally. These lipid-based components offer concentrated energy sources, aiding in the maintenance of healthy body functions. As healthcare providers prioritize tailored nutrition, fats in parenteral nutrition solutions become indispensable for addressing malnutrition, supporting recovery, and meeting the specific dietary needs of patients across diverse medical conditions.
Parenteral nutrition market size from the homecare settings segment will register a noteworthy CAGR from 2023 to 2032. Home-based patients unable to intake food orally benefit from tailored parenteral nutrition solutions. These convenient therapies ensure patients receive vital nutrients intravenously, promoting recovery and sustaining health. As healthcare shifts towards patient-centric homecare, the demand for parenteral nutrition rises, enabling individuals with complex medical needs to receive essential nourishment in the comfort of their homes, enhancing their quality of life and aiding in their recuperation.
Europe parenteral nutrition industry will showcase a commendable CAGR from 2023 to 2032. With an aging population and rising prevalence of chronic conditions, the need for specialized nutritional support amplifies. Parenteral nutrition, addressing critical care, malnutrition, and digestive disorders, becomes vital. Additionally, advancements in formulations and infusion technologies enhance patient outcomes. As European healthcare systems prioritize patient-centric care, the demand for tailored parenteral nutrition solutions rises, reflecting a pivotal era in meeting diverse nutritional needs across the continent.